Our Team

Parkinson’s Disease: Molecular Landscape & Future Disease Modifying Targeted Therapies

The success of targeted therapies in indications like cancer, chronic diseases have paved the way for using this approach in more challenging indications like Parkinson’s.. Read more…

Exploring Opportunities in Niche Therapies – Human Cytomegalovirus (HCMV) Infections

The spectrum of diseases caused by Human Cytomegalovirus (HCMV) is diverse.Most CMV infections are “silent,” where the infected people exhibit … Read more

Innovation in India Series: An Analysis of Select Pharma/Biotech Start-ups

Innovation is still in its nascent stage in the Indian Pharma sector but like the west it is being nurtured in … Read more

CGRP Antagonists /Monoclonal Antibodies: New Targeted Therapies for Migraine

Migraine has been recognized as a highly disabling neurological pain disorder and its management is often … Read more

MPN and its overlaps with MDS

Advances have been made in the genetics and molecular profiling to help define sub-types and develop a treatment … Read more

Oral Mucositis

Oral Mucositis (OM) is a complication of aggressive chemotherapy and radiotherapy treatments in Head … Read more

PARPs Inhibitors

Poly(adenosine diphosphate [ADP]–ribose) polymerases (PARPs) activity is essential for the repair of damaged DNA. Read more